{"id":"fd5648f6-a93c-460e-918c-021449c44e97","name":"Dexcom","slug":"dexcom","description":"Continuous-glucose-monitoring company (NASDAQ: DXCM) whose Stelo is the first FDA-cleared OTC glucose biosensor (no prescription) with a generative-AI insight layer (Vertex AI/Gemini); separate from its prescription G7.","status":"public (NASDAQ: DXCM)","founded":1999,"hq":"San Diego, California, USA","fundingTotal":null,"type":"both","reviewStatus":"reviewed","sources":[{"url":"https://investors.dexcom.com/news/news-details/2024/Stelo-by-Dexcom-First-Glucose-Biosensor-to-be-Cleared-by-FDA-as-Over-the-Counter/default.aspx","title":"Stelo by Dexcom: first glucose biosensor FDA-cleared OTC (De Novo Mar 5 2024; adults 18+ not on insulin)","sourceName":"Dexcom (investor relations)"},{"url":"https://investors.dexcom.com/news/news-details/2024/Dexcom-Launches-the-First-Generative-AI-Platform-in-Glucose-Biosensing/default.aspx","title":"Dexcom launches generative-AI platform for Stelo (Google Cloud Vertex AI + Gemini; Weekly Insights)","sourceName":"Dexcom (investor relations)"},{"url":"https://www.medtechdive.com/news/dexcom-gen-ai-feature-stelo-cgm/735918/","title":"Dexcom gen-AI for Stelo (personalized insights; AI photo meal logging)","sourceName":"MedTech Dive"}],"keyFacts":[{"label":"Product","value":"Stelo OTC glucose biosensor (first FDA-cleared OTC CGM, De Novo Mar 2024) + gen-AI insights (Vertex/Gemini)."},{"label":"Boundary","value":"Glucose-biometric + real AI -> in-definition INCLUDE (not a bare sensor)."},{"label":"wikipedia","value":"https://en.wikipedia.org/wiki/Dexcom"},{"label":"wikidata","value":"https://www.wikidata.org/wiki/Q15109865"}],"aliases":["DexCom Inc","Stelo"],"collisionRisk":"low","reviewNote":null,"createdAt":"2026-06-03T22:46:45.745Z","updatedAt":"2026-06-03T23:26:19.526Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/dexcom","url":"https://registry.deploy.report/companies/dexcom","name":"Dexcom","alternateName":["DexCom Inc","Stelo"],"description":"Continuous-glucose-monitoring company (NASDAQ: DXCM) whose Stelo is the first FDA-cleared OTC glucose biosensor (no prescription) with a generative-AI insight layer (Vertex AI/Gemini); separate from its prescription G7.","identifier":["fd5648f6-a93c-460e-918c-021449c44e97",{"@type":"PropertyValue","propertyID":"wikidata","value":"Q15109865"}],"foundingDate":"1999","address":"San Diego, California, USA","sameAs":["https://en.wikipedia.org/wiki/Dexcom","https://www.wikidata.org/wiki/Q15109865"],"publisher":{"@id":"https://deploy.report/#organization"}}}